ALPS Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $923K | Sell |
14,707
-2,593
| -15% | -$207K | ﹤0.01% | 596 |
|
|
2025
Q4 | $1.65M | Buy |
17,300
+1,291
| +8% | +$127K | 0.01% | 429 |
|
|
2025
Q3 | $1.56M | Buy |
16,009
+592
| +4% | +$61.3K | 0.01% | 427 |
|
|
2025
Q2 | $1.66M | Sell |
15,417
-2,042
| -12% | -$207K | 0.01% | 393 |
|
|
2025
Q1 | $1.76M | Buy |
17,459
+1,708
| +11% | +$172K | 0.01% | 367 |
|
|
2024
Q4 | $1.41M | Sell |
15,751
-492
| -3% | -$43.3K | 0.01% | 403 |
|
|
2024
Q3 | $1.36M | Sell |
16,243
-9,513
| -37% | -$750K | 0.01% | 423 |
|
|
2024
Q2 | $1.98M | Sell |
25,756
-3,830
| -13% | -$280K | 0.01% | 336 |
|
|
2024
Q1 | $2.03M | Buy |
29,586
+2,620
| +10% | +$168K | 0.01% | 346 |
|
|
2023
Q4 | $1.56M | Sell |
26,966
-1,760
| -6% | -$93.9K | 0.01% | 371 |
|
|
2023
Q3 | $1.52M | Sell |
28,726
-690
| -2% | -$36.2K | 0.01% | 365 |
|
|
2023
Q2 | $1.59M | Buy |
29,416
+977
| +3% | +$51K | 0.01% | 357 |
|
|
2023
Q1 | $1.42M | Sell |
28,439
-934
| -3% | -$44K | 0.01% | 371 |
|
|
2022
Q4 | $1.36M | Sell |
29,373
-5,188
| -15% | -$225K | 0.01% | 380 |
|
|
2022
Q3 | $1.34M | Sell |
34,561
-1,450
| -4% | -$58.2K | 0.01% | 384 |
|
|
2022
Q2 | $1.34M | Sell |
36,011
-9,959
| -22% | -$405K | 0.01% | 397 |
|
|
2022
Q1 | $2.04M | Sell |
45,970
-19,706
| -30% | -$854K | 0.02% | 204 |
|
|
2021
Q4 | $2.79M | Sell |
65,676
-43,613
| -40% | -$1.83M | 0.03% | 206 |
|
|
2021
Q3 | $4.74M | Sell |
109,289
-363
| -0.3% | -$16.1K | 0.05% | 177 |
|
|
2021
Q2 | $4.69M | Sell |
109,652
-1,497
| -1% | -$63K | 0.04% | 178 |
|
|
2021
Q1 | $4.3M | Sell |
111,149
-11,233
| -9% | -$425K | 0.04% | 186 |
|
|
2020
Q4 | $4.4M | Buy |
122,382
+42,061
| +52% | +$1.52M | 0.05% | 184 |
|
|
2020
Q3 | $3.07M | Buy |
80,321
+7,701
| +11% | +$297K | 0.05% | 191 |
|
|
2020
Q2 | $2.55M | Buy |
72,620
+24,922
| +52% | +$898K | 0.03% | 211 |
|
|
2020
Q1 | $1.56M | Buy |
47,698
+22,457
| +89% | +$877K | 0.02% | 230 |
|
|
2019
Q4 | $1.14M | Buy |
25,241
+269
| +1% | +$11.3K | 0.01% | 324 |
|
|
2019
Q3 | $1.02M | Buy |
24,972
+7,742
| +45% | +$328K | 0.01% | 303 |
|
|
2019
Q2 | $741K | Buy |
17,230
+1,874
| +12% | +$72.1K | 0.01% | 410 |
|
|
2019
Q1 | $589K | Buy |
15,356
+1,330
| +9% | +$50.8K | ﹤0.01% | 457 |
|
|
2018
Q4 | $496K | Sell |
14,026
-1,961
| -12% | -$71.1K | ﹤0.01% | 480 |
|
|
2018
Q3 | $615K | Buy |
15,987
+3,993
| +33% | +$139K | ﹤0.01% | 507 |
|
|
2018
Q2 | $392K | Buy |
11,994
+4,666
| +64% | +$141K | ﹤0.01% | 782 |
|
|
2018
Q1 | $200K | Buy |
+7,328
| New | +$199K | ﹤0.01% | 849 |
|
Other funds holding BSX
VCM
VPM
ALPS Advisors's BSX Position: Q1 2026 in Review
ALPS Advisors reduced its Boston Scientific (BSX) stake by 15% in Q1 2026, selling an estimated $207K and leaving 14,707 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #596.
ALPS Advisors first reported a position in BSX in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.74M in Q3 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- ALPS Advisors held 14,707 shares of Boston Scientific worth $923K as of Q1 2026.
- ALPS Advisors sold 2,593 Boston Scientific shares in Q1 2026, an estimated $207K.
- Boston Scientific made up ﹤0.01% of ALPS Advisors's portfolio in Q1 2026, its #596 holding.
- ALPS Advisors first reported a position in Boston Scientific in Q1 2018 and has held it in 33 quarters since.
- ALPS Advisors's Boston Scientific position peaked at $4.74M in Q3 2021.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.